Search Results - "DI TUCCI, Anna"

Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes by VOSO, Maria Teresa, SANTINI, Valeria, BUCCISANO, Francesco, GOBBI, Marco, BORIN, Lorenza, DI TUCCI, Anna, ZINI, Gina, PETTI, Maria Concetta, MARTINELLI, Giovanni, FABIANI, Emiliano, FAZI, Paola, VIGNETTI, Marco, FINELLI, Carlo, PICIOCCHI, Alfonso, LISO, Vincenzo, AMADORI, Sergio, LEONE, Giuseppe, MUSTO, Pellegrino, POGLIANI, Enrico, ANGELUCCI, Emanuele, FIORITONI, Giuseppe, ALIMENA, Giuliana, MAURILLO, Luca, CORTELEZZI, Agostino

“…Purpose: Epigenetic changes play a role and cooperate with genetic alterations in the pathogenesis of myelodysplastic syndromes (MDS). We conducted a phase II…”
Get full text

Myocardial iron overload assessment by T2 magnetic resonance imaging in adult transfusion dependent patients with acquired anemias by Di Tucci, Anna Angela, Matta, Gildo, Deplano, Simona, Gabbas, Attilio, Depau, Cristina, Derudas, Daniele, Caocci, Giovanni, Agus, Annalisa, Angelucci, Emanuele

“…1 Ematologia e Centro Trapianti, Centro Oncologico di Riferimento regionale "Armando Businco", Cagliari 2 Radiologia Ospedale "Brotzu", Cagliari 3 Ematologia…”
Get full text

Iron overload, cardiac iron loading and function in myelodysplastic syndrome by Angelucci, Emanuele, Tucci, Anna Angela Di

Get full text

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial by Angelucci, Emanuele, Li, Junmin, Greenberg, Peter, Wu, Depei, Hou, Ming, Montano Figueroa, Efreen Horacio, Rodriguez, Maria Guadalupe, Dong, Xunwei, Ghosh, Jagannath, Izquierdo, Miguel, Garcia-Manero, Guillermo

“…Iron chelation therapy (ICT) in patients with lower-risk myelodysplastic syndromes (MDS) has not been evaluated in randomized studies. To evaluate event-free…”
Get full text

Patient‐reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes by Efficace, Fabio, Cottone, Francesco, Abel, Gregory, Niscola, Pasquale, Gaidano, Gianluca, Bonnetain, Franck, Anota, Amelie, Caocci, Giovanni, Cronin, Angel, Fianchi, Luana, Breccia, Massimo, Stauder, Reinhard, Platzbecker, Uwe, Palumbo, Giuseppe A., Luppi, Mario, Invernizzi, Rosangela, Bergamaschi, Micaela, Borin, Lorenza, Di Tucci, Anna Angela, Zhang, Huiyong, Sprangers, Mirjam, Vignetti, Marco, Mandelli, Franco

“…BACKGROUND Current prognostic systems for myelodysplastic syndromes (MDS) are based on clinical, pathologic, and laboratory indicators. The objective of the…”
Get full text

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial) by Angelucci, Emanuele, Santini, Valeria, Di Tucci, Anna Angela, Quaresmini, Giulia, Finelli, Carlo, Volpe, Antonio, Quarta, Giovanni, Rivellini, Flavia, Sanpaolo, Grazia, Cilloni, Daniela, Salvi, Flavia, Caocci, Giovanni, Molteni, Alfredo, Vallisa, Daniele, Voso, Maria Teresa, Fenu, Susanna, Borin, Lorenza, Latte, Giancarlo, Alimena, Giuliana, Storti, Sergio, Piciocchi, Alfonso, Fazi, Paola, Vignetti, Marco, Tura, Sante

“…Background In the absence of randomized, controlled trial data to support iron chelation therapy in transfusion‐dependent patients with myelodysplastic…”
Get full text

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice by Clavio, Marino, Crisà, Elena, Miglino, Maurizio, Guolo, Fabio, Ceccarelli, Manuela, Salvi, Flavia, Allione, Bernardino, Ferrero, Dario, Balleari, Enrico, Finelli, Carlo, Poloni, Antonella, Selleri, Carmine, Danise, Paolo, Cilloni, Daniela, Di Tucci, Anna Angela, Cametti, Gianni, Freilone, Roberto, Fanin, Renato, Bigazzi, Catia, Zambello, Renato, Crugnola, Monica, Oliva, Esther N., Centurioni, Riccardo, Alesiani, Francesco, Catarini, Massimo, Castelli, Andrea, Abbadessa, Antonio, Capalbo, Silvana F., Musto, Pellegrino, Angelucci, Emanuele, Santini, Valeria

“…Background Azacitidine (AZA) is the standard treatment for myelodysplastic syndromes (MDS); however, many patients prematurely stop therapy and have a dismal…”
Get full text

Dramatic erythroid response to low‐dose thalidomide in two patients with transfusion independent thalassemia and severe post‐transfusional alloimmune hemolysis by Fozza, Claudio, Pardini, Simonetta, Giannico, Domenica Barbara, Targhetta, Clara, Di Tucci, Anna Angela, Dessalvi, Paolo, Angelucci, Emanuele, Dore, Fausto

Get full text

Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion‐dependent patients with myelodysplastic syndromes by Piciocchi, Alfonso, Sargentini, Valeria, Cotugno, Francesca, Bontempi, Katia, Beltrami, Germana, Di Tucci, Anna Angela, Riva, Marta, Quaresmini, Giulia, Vallisa, Daniele, Finelli, Carlo, Borin, Lorenza, Fazi, Paola, Vignetti, Marco, Angelucci, Emanuele

Get full text

Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study by Baronciani, Donatella, Depau, Cristina, Targhetta, Clara, Usai, Sara Veronica, Di Tucci, Anna Angela, Romani, Claudio, Tandurella, Igor, Angelucci, Emanuele

“…Background. Autologous stem cell transplant is a consolidation treatment for standard risk acute myeloid leukemia (AML). Traditional preparative regimens, most…”
Get full text

Once Daily Intravenous Busulphan Plus Fludarabine As New Reduced Toxicity Myeloablative Conditioning for Acute Myeloid Leukemia and MDS Allogeneic Transplantation by Baronciani, Donatella, Depau, Cristina, Targhetta, Clara, Di Tucci, Anna Angela, Derudas, Daniele, Culurgioni, Fabio, Pulisci, Donatella, Tandurella, Igor, Angelucci, Emanuele

“…▪ Background. Allogeneic hemopoietic stem cell transplantation is the treatment of choice for high and intermediate risk acute myeloid leukemia (AML) and for…”
Get full text

Impact of Transfusion Dependency on Health-Related Quality of Life Outcomes in Newly Diagnosed Patients with Myelodysplastic Syndromes (MDS). Analysis on 669 Patients By Disease Risk by Efficace, Fabio, Niscola, Pasquale, Gaidano, Gianluca, Ricco, Alessandra, Caocci, Giovanni, Breccia, Massimo, Palumbo, Giuseppe A, Voso, Maria Teresa, Vallisa, Daniele, Allione, Bernardino, Canicattì, Manuela, Okumura, Iris, Cottone, Francesco, Invernizzi, Rosangela, Bergamaschi, Micaela, Borin, Lorenza Maria, Di Tucci, Anna Angela, Zhang, Huiyong, Stauder, Reinhard, Platzbecker, Uwe, Luppi, Mario, Petranovic, Duska, Caers, Jo, Cascavilla, Nicola, Vignetti, Marco, Mandelli, Franco

“…Background: There is some evidence indicating that transfusion dependency negatively impact health-related quality of life HRQOL of patients with…”
Get full text

Inclusion of Patient's Self-Reported Fatigue into a Standard Laboratory Risk Classification Enhances Survival Prediction in Patients with Advanced Myelodysplastic Syndromes by Efficace, Fabio, Niscola, Pasquale, Cottone, Francesco, Gaidano, Gianluca, Anota, Amelie, Bonnetain, Franck, Caocci, Giovanni, Fianchi, Luana, Breccia, Massimo, Stauder, Reinhard, Platzbecker, Uwe, Palumbo, Giuseppe A, Luppi, Mario, Invernizzi, Rosangela, Bergamaschi, Micaela, Fedele, Marilena, Di Tucci, Anna Angela, Zhang, Huiyong, Vignetti, Marco, Mandelli, Franco

“…BACKGROUND: Patients with higher risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System (IPSS) have poor life expectancy…”
Get full text

Clinical Outcomes of 420 MDS Patients Treated with 5-Azacytidine: Evaluation of Overall Survival, Duration of Treatment and Rate of Discontinuation in a Real Life Study from the Italian MDS Registry of Fondazione Italiana Sindromi Mielodisplastiche (FISM) by Clavio, Marino, Gioia, Daniela, Ceccarelli, Manuela, Monagheddu, Chiara, Balleari, Enrico, Miglino, Maurizio, Di Tucci, Anna Angela, Allione, Bernardino, Poloni, Antonella, Finelli, Carlo, Aguzzi, Chiara, Selleri, Carmine, Danise, Paolo, Cilloni, Daniela, Gaidano, Valentina, Cavaliere, Marina, Calzamiglia, Tullio, Freilone, Roberto, Cametti, Gianni, Conconi, Anna Rita, Mezzabotta, Mauro, Goretti, Riccardo, Musto, Pellegrino, Gaidano, Gianluca, Pane, Fabrizio, Angelucci, Emanuele, Levis, Alessandro, Santini, Valeria

“…▪ Introduction Azacytidine(AZA) is the current standard of care for patients with high-risk myelodysplastic syndrome (MDS) in Europe. AZA has shown a survival…”
Get full text

Higher Versus Standard Doses of Recombinant Erythropoietin for the Treatment of Anemia in Patients with Myelodysplastic Syndromes: Results of a Retrospective Survey from the Italian Registry of Myelodisplastic Syndromes (FISM) by Balleari, Enrico, Filiberti, Rosa, Salvetti, Chiara, Allione, Bernardino, Angelucci, Emanuele, Calzamiglia, Tullio, Cavaliere, Marina, Cilloni, Daniela, Clavio, Marino, Da Col, Anna, Danise, Paolo, Di Tucci, Anna Angela, Ferrero, Dario, Finelli, Carlo, Gioia, Daniela, Lemoli, Roberto M, Levis, Alessandro, Messa, Emanuela, Masera, Elisa, Miglino, Maurizio, Musto, Pellegrino, Oliva, Esther Natalie, Poloni, Antonella, Scudeletti, Marco, Tassara, Rodolfo, Santini, Valeria

“…▪ Introduction: Erythropoietic stimulating agents (ESAs) have not yet received FDA nor EMA approval to treat anemia of myelodysplastic syndromes (MDS), but…”
Get full text

A genome wide association study by Immunochip reveals potential modifiers in myelodysplastic syndromes by Danjou, Fabrice, Fozza, Claudio, Dr, Zoledziewska, Magdalena, Mulas, Antonella, Corda, Giovanna, Contini, Salvatore, Dore, Fausto, Galleu, Antonio, Di Tucci, Anna Angela, Caocci, Giovanni, Gaviano, Eleonora, Latte, Giancarlo, Gabbas, Attilio, Casula, Paolo, Delogu, Lucia Gemma, La Nasa, Giorgio, Angelucci, Emanuele, Cucca, Francesco, Longinotti, Maurizio

“…Abstract As different findings suggest that an immune dysregulation play a role in the pathogenesis of MDS, we analysed a large cohort of patients from a…”
Get full text

Correction of anemia in a transfusion‐dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670) by Di Tucci, Anna Angela, Murru, Roberta, Alberti, Daniele, Rabault, Bertrand, Deplano, Simona, Angelucci, Emanuele

“…Transfusional iron overload in patients with chronic anemias can result in multiple organ failure. Experience in the management of iron overload in patients…”
Get full text

Health-Related Quality Of Life In Transfusion-Dependent Patients With Myelodysplastic Syndromes Treated With Deferasirox. A Multicenter Prospective Study by Efficace, Fabio, Santini, Valeria, La Nasa, Giorgio, Cottone, Francesco, Finelli, Carlo, Borin, Lorenza, Quaresmini, Giulia, Di Tucci, Anna, Volpe, Antonio, Cilloni, Daniela, Quarta, Giovanni, Sanpaolo, Grazia, Rivellini, Flavia, Salvi, Flavia, Molteni, Alfredo, Vallisa, Daniele, Storti, Sergio, Voso, Maria Teresa, Alimena, Giuliana, Fenu, Susanna, Vignetti, Marco, Mandelli, Franco, Angelucci, Emanuele

“…Anemia is a common symptom in patients with Myelodysplastic Syndromes (MDS) and although erythropoietic agents are often active, it is frequently treated with…”
Get full text

Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy by Efficace, Fabio, Santini, Valeria, La Nasa, Giorgio, Cottone, Francesco, Finelli, Carlo, Borin, Lorenza, Quaresmini, Giulia, Di Tucci, Anna Angela, Volpe, Antonio, Cilloni, Daniela, Quarta, Giovanni, Sanpaolo, Grazia, Rivellini, Flavia, Salvi, Flavia, Molteni, Alfredo, Voso, Maria Teresa, Alimena, Giuliana, Fenu, Susanna, Mandelli, Franco, Angelucci, Emanuele

“…The primary objective of this study was to evaluate the health-related quality of life (HRQOL) in lower-risk, transfusion-dependent patients with…”
Get more information

The evolving clinical scenario of myelodysplastic syndrome: The need for a complete and up to date upfront diagnostic assessment by Pilo, Federica, Di Tucci, Anna Angela, Dessalvi, Paolo, Caddori, Aldo, Angelucci, Emanuele

“…Abstract Until the beginning of the current millennium, few concrete therapeutic possibilities were available for myelodysplastic syndrome (MDS) patients. This…”
Get full text